These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4144834)

  • 1. The inhibition of pineal hydroxyindole-O-methyltransferase by haloperidol and fluphenazine.
    Hartley R; Padwick D; Smith JA
    J Pharm Pharmacol; 1972 Dec; 24():Suppl:100P-103. PubMed ID: 4144834
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of hydroxyindole-O-methyltransferase: indolealkylpiperazines.
    Ho BT; Gardner PM; McIsaac WM
    J Pharm Sci; 1973 Mar; 62(3):508-9. PubMed ID: 4691720
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of retinal and pineal low molecular weight fractions and antipsychotic drugs on hydroxyindole-O-methyltransferase.
    Cremer-Bartels G; Ebels I; Sykes JE; de Morée A
    J Neural Transm; 1983; 58(1-2):107-19. PubMed ID: 6140301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of inhibition of pineal hydroxyindole-O-methyltransferase by pyridoxal 5'-phosphate.
    Borchardt RT; Wu YS; Wu BS
    Biochem Pharmacol; 1978 Jan; 27(1):120-2. PubMed ID: 619896
    [No Abstract]   [Full Text] [Related]  

  • 5. Formation in vitro of N-acetyl-3,4-dimethoxyphenethylamine by pineal hydroxy-indole-O-methyl transferase.
    Hartley R; Smith JA
    Biochem Pharmacol; 1973 Oct; 22(19):2425-8. PubMed ID: 4745637
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of pineal hydroxyindole-O-methyl transferase by pyridoxal-5'-phosphate.
    Nir I; Hirschmann N; Sulman FG
    Biochem Pharmacol; 1976 Mar; 25(5):581-3. PubMed ID: 945987
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor of indolethylamine N-methyltransferase in pineal extract.
    Narasimhachari N; Lin RL; Himwich HE
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):375-8. PubMed ID: 4438840
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of light on the development of a diurnal rhythm in serotonin content and on the development of hydroxyindole-o-methyl transferase activity in the rat pineal gland.
    Illnerová H
    Act Nerv Super (Praha); 1972; 14(2):130-1. PubMed ID: 5040162
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxyindole-0-methyltransferase. VI. Inhibitory activities of substituted benzoyltryptamines and benzenesulfonyltryptamines.
    Ho BT; Noel MB; Tansey LW
    J Pharm Sci; 1971 Apr; 60(4):636-7. PubMed ID: 5166868
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification of bovine pineal hydroxyindole O-methyltransferase by immunoadsorption chromatography.
    Kuwano R; Yoshida Y; Takahashi Y
    J Neurochem; 1978 Oct; 31(4):815-24. PubMed ID: 29942
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies to hydroxyindole O-methyltransferase from bovine pineal gland.
    Deguchi T; Yokoyama E; Ichikawa T
    Brain Res; 1987 Jul; 388(2):89-98. PubMed ID: 3113661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action spectra for effects of light on hydroxyindole-o-methyl transferases in rat pineal, retina and harderian gland.
    Cardinali DP; Larin F; Wurtman RJ
    Endocrinology; 1972 Oct; 91(4):877-86. PubMed ID: 5051343
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunocytochemical localisation of hydroxyindole-O-methyltransferase in pineal photoreceptor cells of several fish species.
    Falcón J; Bégay V; Goujon JM; Voisin P; Guerlotté J; Collin JP
    J Comp Neurol; 1994 Mar; 341(4):559-66. PubMed ID: 8201028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential inhibitor of S-adenosylmethionine-dependent methyltransferases. 2. Modification of the base portion of S-adenosylhomocysteine.
    Borchardt RT; Huber JA; Wu YS
    J Med Chem; 1974 Aug; 17(8):868-73. PubMed ID: 4845380
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine.
    Borchardt RT; Wu YS
    J Med Chem; 1974 Aug; 17(8):862-8. PubMed ID: 4845379
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic drugs and erythrocyte catechol-O-methyltransferase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Biol Psychiatry; 1982 Nov; 17(11):1339-42. PubMed ID: 6129906
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of N-and O-methyltransferases.
    Axelrod J; Vesell ES
    Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of hydroxyindole-O-methyltransferase gene expression in the pineal gland and retina.
    Voisin P; Guerlotte J; Bernard M; Greve P; Grechez-Cassiau A; Collin JP
    Acta Neurobiol Exp (Wars); 1994; 54 Suppl():41-6. PubMed ID: 7801791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.